Peter Barton Hutt is Director of Moderna, Inc.. Currently has a direct ownership of 3,924 shares of MRNA, which is worth approximately $157,470. The most recent transaction as insider was on Nov 20, 2019, when has been sold 200,000 shares (Common Stock) at a price of $20.18 per share, resulting in proceeds of $4,036,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.92K
0% 3M change
0% 12M change
Total Value Held $157,470

PETER BARTON HUTT Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 20 2019
SELL
Open market or private sale
$4,036,000 $20.18 p/Share
200,000 Reduced 98.08%
3,924 Common Stock
Nov 20 2019
BUY
Exercise of conversion of derivative security
$8,000 $0.04 p/Share
200,000 Added 49.51%
203,924 Common Stock
Sep 17 2019
SELL
Open market or private sale
$1,763,000 $17.63 p/Share
100,000 Reduced 96.22%
3,924 Common Stock
Sep 17 2019
BUY
Exercise of conversion of derivative security
$4,000 $0.04 p/Share
100,000 Added 49.04%
103,924 Common Stock

Also insider at

IMMU
IMMUNOMEDICS INC
CNCE
CONCERT PHARMACEUTICALS, INC. Healthcare
PBH

Peter Barton Hutt

Director
Cambridge, MA

Track Institutional and Insider Activities on MRNA

Follow Moderna, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

News

Receive news related to Moderna, Inc.

Track Activities on MRNA